Back to search results

Evaluation of Inflammatory Markers in ph Negative Myeloproliferative Neoplasms: Impact on Outcome and Response to Therapy. Multicenter Retro-prospective Observational Study. The INFLA-ME (INFLAmmation in Myeloproliferative Disease) Study.

Abroad (travel likely)Recruiting

Conditions

Myeloproliferative Disease · Inflammatory Markers

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Azienda Ospedaliera Universitaria Consorziale Policlinico, Bari, Italy

    Contact: Study coordinator (Pellegrino Musto) · pellegrino.musto@uniba.it

  • Policlinico Sant'Orsola Malpighi, Bologna, Italy

    Contact: Study coordinator (Francesca Palandri) · francesca.palandri@unibo.it

  • ASST Spedali Civili di Brescia, Brescia, Italy

    Contact: Study coordinator (Nicola Polverelli) · nicola.polverelli@gmail.com

  • Policlinico Vittorio Emanuele, Catania, Italy

    Contact: Study coordinator (Giuseppe Alberto Palumbo) · palumbo.giuseppealberto@gmail.com

  • Ospedale Universitario Federico II, Naples, Italy

    Contact: Study coordinator (Novella Pugliese) · novypugliese@yahoo.it

  • Policlinico Umberto I, Università La Sapienza, Roma, Italy

    Contact: Study coordinator (Massimo Breccia)

  • Azienda Ospedaliera Universitaria Città della Salute e delle Scienza, Torino, Italy

    Contact: Study coordinator (Giulia Benevolo) · gbenevolo@cittadellasalute.to.it

  • Ospedale San Luigi di Orbassano - Ospedale Mauriziano, Torino, Italy

    Contact: Study coordinator (Daniela Cilloni) · daniela.cilloni@unito.it

  • Azienda Ospedaliera Universitaria Friuli Centrale, Udine, Italy

    Contact: Study coordinator (Mario Tiribelli) · mario.tiribelli@uniud.it

  • Azienda Ospedaliera Universitaria Integrata, Verona, Italy

    Contact: Study coordinator (Massimiliano Bonifacio) · massimiliano.bonifacio@univr.it

  • Ospedale Belcolle, Viterbo, Italy

    Contact: Study coordinator (Roberto Latagliata) · rob.lati@libero.it
View source on ClinicalTrials.gov(opens in a new tab)